Clinical Trial Update: Study of Various Treatments in Non-alcoholic Fatty Liver Disease (NAFLD) Patients Who Have Aspects of Non-alcoholic Steatohepatitis (NASH) [Phase 2]

View source ↗

Summary

Phase 2 trial update for various treatments in NAFLD with aspects of NASH; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis

Drugs mentioned

• Novartis Pharmaceuticals

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Non-alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis | Phase 2 | Status: TERMINATED | Results posted: 2023-01-26